Number of Shares
1.52 Mil
Current Holdings Value*
$16.77 Mil
% of Portfolio
11.18%
Total Estimate Gain
$5.02 Mil
% of Total Estimate Gain
27.68%

ACORN CAPITAL ADVISORS, LLC's UroGen Pharma Ltd Holding Summary

As of 2025-03-31, ACORN CAPITAL ADVISORS, LLC held 1.52 Mil shares of UroGen Pharma Ltd(URGN), totaling $16.77 Mil. This investment constitutes 11.18% of their stock portfolio, and ACORN CAPITAL ADVISORS, LLC now holds 3.29% of the outstanding UroGen Pharma Ltd(URGN) stock.

The initial trade took place in 2024Q4. Based on historical transaction data and URGN's current price of $15.27, ACORN CAPITAL ADVISORS, LLC's estimated gain on his URGN holdings is $5.02 Mil, reflecting a 27.68% gain to date.

ACORN CAPITAL ADVISORS, LLC URGN ($15.27) Holding Chart

ACORN CAPITAL ADVISORS, LLC URGN ($15.27) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1